Home
Live Updates
Ankyra Therapeutics and Jenga Biosciences Announce Exclusive License Agreement for JEN-101 : comparemela.com
Ankyra Therapeutics and Jenga Biosciences Announce Exclusive License Agreement for JEN-101
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 26, 2024--
Related Keywords
Massachusetts ,
United States ,
Ankyra ,
Ankara ,
Turkey ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Howard Kaufman ,
Julia Stephanus ,
Rob Tighe ,
Howardl Kaufman ,
Jenga Biosciences ,
,
Chief Scientific Officer ,
Chief Executive Officer ,
Executive Chair ,
Borealis Ventures ,
For Ankyra Media ,
Investor Inquiries ,
Business Wire ,
comparemela.com © 2020. All Rights Reserved.